TY - JOUR
T1 - Proceedings of the IASLC international workshop on advances in pulmonary neuroendocrine tumors 2007
AU - Lim, Eric
AU - Goldstraw, Peter
AU - Nicholson, Andrew G.
AU - Travis, William D.
AU - Jett, James R.
AU - Ferolla, Piero
AU - Bomanji, Jamshed
AU - Rusch, Valerie W.
AU - Asamura, Hisao
AU - Skogseid, Britt
AU - Baudin, Eric
AU - Caplin, Martyn
AU - Kwekkeboom, Dik
AU - Brambilla, Elisabeth
AU - Crowley, John
PY - 2008/10
Y1 - 2008/10
N2 - The International Association for the Study of Lung Cancer, (IASLC) International Congress on Advances in Pulmonary Neuroendocrine Tumors was a two-day meeting held at the Royal Brompton Hospital in London, United Kingdom on the thirteenth and forteenth of December 2007. The meeting was led by 14 member international faculty-in the disciplines of pathology, surgery, medicine, oncology, endocrinology, nuclear medicine, diagnostic imaging, and biostatistics. The aims were twofold, as an educational meeting, and to develop the IASLC International Pulmonary Neuroendocrine Tumors Registry. The meeting highlighted the difference in presentation of the tumors, management options for early and advanced stage disease including the use of novel agents and approaches. The need, process, and approach to an International Registry of Pulmonary Neuroendocrine Tumors were emphasized. International collaboration to develop a retrospective registry, prospective data collection, virtual tissue bank, and collaborative clinical trials were universally agreed as the best way to advance our understanding and treatment of these rare tumors.
AB - The International Association for the Study of Lung Cancer, (IASLC) International Congress on Advances in Pulmonary Neuroendocrine Tumors was a two-day meeting held at the Royal Brompton Hospital in London, United Kingdom on the thirteenth and forteenth of December 2007. The meeting was led by 14 member international faculty-in the disciplines of pathology, surgery, medicine, oncology, endocrinology, nuclear medicine, diagnostic imaging, and biostatistics. The aims were twofold, as an educational meeting, and to develop the IASLC International Pulmonary Neuroendocrine Tumors Registry. The meeting highlighted the difference in presentation of the tumors, management options for early and advanced stage disease including the use of novel agents and approaches. The need, process, and approach to an International Registry of Pulmonary Neuroendocrine Tumors were emphasized. International collaboration to develop a retrospective registry, prospective data collection, virtual tissue bank, and collaborative clinical trials were universally agreed as the best way to advance our understanding and treatment of these rare tumors.
KW - Atypical carcinoid
KW - Carcinoma
KW - Large cell neuroendocrine
KW - Neuroendocrine tumours
KW - Typical carcinoid
UR - http://www.scopus.com/inward/record.url?scp=58949094479&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58949094479&partnerID=8YFLogxK
U2 - 10.1097/JTO.0b013e3181861d7b
DO - 10.1097/JTO.0b013e3181861d7b
M3 - Article
C2 - 18827620
AN - SCOPUS:58949094479
SN - 1556-0864
VL - 3
SP - 1194
EP - 1201
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
IS - 10
ER -
